Verheijen, R. B. http://orcid.org/0000-0002-8804-1020
van Duijl, T. T.
van den Heuvel, M. M.
Vessies, D.
Muller, M.
Beijnen, J. H.
Janssen, J. M.
Schellens, J. H. M.
Steeghs, N.
van den Broek, D.
Huitema, A. D. R.
Article History
Received: 28 May 2020
Accepted: 5 January 2021
First Online: 23 January 2021
Compliance with ethical standards
:
: Remy Verheijen is an employee and shareholder of AstraZeneca and Johnson & Johnson. All other authors declare they have no conflicts to disclose.
: For this retrospective observational study, no informed consent was required in accordance with code of conduct for responsible use of human tissue and medical research [CitationRef removed].
: For this retrospective observational study, no informed consent was required in accordance with code of conduct for responsible use of human tissue and medical research [CitationRef removed].